Pre-vaccination inflammation and B-cell signalling predict age-related hyporesponse to hepatitis B vaccination
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Aging is associated with hyporesponse to vaccination, whose mechanisms remain unclear. In this study hepatitis B virus (HBV)-naive older adults received three vaccines, including one against HBV. Here we show, using transcriptional and cytometric profiling of whole blood collected before vaccination, that heightened expression of genes that augment B-cell responses and higher memory B-cell frequencies correlate with stronger responses to HBV vaccine. In contrast, higher levels of inflammatory response transcripts and increased frequencies of pro-inflammatory innate cells correlate with weaker responses to this vaccine. Increased numbers of erythrocytes and the haem-induced response also correlate with poor response to the HBV vaccine. A transcriptomics-based pre-vaccination predictor of response to HBV vaccine is built and validated in distinct sets of older adults. This moderately accurate (area under the curve≈65%) but robust signature is supported by flow cytometry and cytokine profiling. This study is the first that identifies baseline predictors and mechanisms of response to the HBV vaccine.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures






Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“SCI can also impair normal immune function, leading to increased susceptibility to infections and tumors and a poor response to vaccines22–25.”
From Chronic inflammation in the etiology of disease across the life span (2019) · cites this paper as [24]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“This may help explain why mediators of systemic chronic inflammation have been linked to suboptimal vaccine responses in not only the elderly26,27 but in younger individuals as well28.”
From SARS-CoV-2, COVID-19 and the aging immune system (2021) · cites this paper as [26]
The cited source says what the claim attributes to it.
In the citing paper
“previous reports showing that high levels of baseline inflammatory markers correlate with weaker responses to hepatitis B and herpes zoster vaccine formulations15,91.”
From An inflammatory aging clock (iAge) based on deep learning tracks multimorbidity, immunosenescence, frailty and cardiovascular aging (2021) · cites this paper as [91]
In the citing paper
“Elevated SCI has also been shown to predict hyporesponsiveness to the hepatitis B vaccine in humans24”
From Chronic inflammation in the etiology of disease across the life span (2019) · cites this paper as [24]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
Bioconductor: open software development for computational biology and bioinformatics
Gentleman, R. C., Carey, V. J., Bates, D. M., Bolstad, B., Dettling, M., Dudoit, S., Ellis, B., Gautier, L., Ge, Y., Gentry, J., et al. (2004) · Genome Biology · doi:10.1186/gb-2004-5-10-r80 · Cited by 12,172
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
Irizarry, R. A. (2003) · Biostatistics · doi:10.1093/biostatistics/4.2.249 · Cited by 10,603
Estimating the Number of Clusters in a Data Set Via the Gap Statistic
Tibshirani, R., Walther, G., & Hastie, T. (2001) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/1467-9868.00293 · Cited by 6,205
Genomic responses in mouse models poorly mimic human inflammatory diseases
Seok, J., Warren, H. S., Cuenca, A. G., Mindrinos, M. N., Baker, H. V., Xu, W., Richards, D. R., McDonald-Smith, G. P., Gao, H., Hennessy, L., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222878110 · Cited by 3,005
Enrichment Map: A Network-Based Method for Gene-Set Enrichment Visualization and Interpretation
Merico, D., Isserlin, R., Stueker, O., Emili, A., & Bader, G. D. (2010) · PLoS ONE · doi:10.1371/journal.pone.0013984 · Cited by 2,235
Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans
Querec, T. D., Akondy, R. S., Lee, E. K., Cao, W., Nakaya, H. I., Teuwen, D., Pirani, A., Gernert, K., Deng, J., Marzolf, B., et al. (2009) · Nature Immunology · doi:10.1038/ni.1688 · Cited by 1,121
Age-dependent dysregulation of innate immunity
Shaw, A. C., Goldstein, D. R., & Montgomery, R. R. (2013) · Nature Reviews Immunology · doi:10.1038/nri3547 · Cited by 1,061
Gavazzi, G., & Krause, K.-H. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00437-1 · Cited by 990
MAQC Consortium (2010) · Nature Biotechnology · doi:10.1038/nbt.1665 · Cited by 889
Cited by
Items 101–198 of 198
An innate immune activation state prior to vaccination predicts responsiveness to multiple vaccinesPreprint
Fourati, S., Tomalin, L. E., Mulè, M., Chawla, D. G., Gerritsen, B., Rychkov, D., Henrich, E., Miller, H., Hagan, T., Diray‐Arce, J., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.26.461847 · Cited by 10
Self-citationPrecision adjuvants for pediatric vaccines
Singh, A., Boggiano, C., Yin, D. E., Polakowski, L., Majji, S., Leitner, W. W., Levy, O., & Paris, K. D. (2024) · Science Translational Medicine · doi:10.1126/scitranslmed.abq7378 · Cited by 9
“In adults, pan-vaccine analysis, leveraging integrative systems vaccinology approaches, has revealed that prevaccination proinflammatory endotypes, amenable to immune activation, represent a key determinant of vaccine responsiveness ( 25 ).”
BackgroundLodge, S., Masuda, R., Nitschke, P., Beilby, J. P., Hui, J., Hunter, M. L., Litton, E., Raby, E., Currie, A. J., Yeap, B. B., et al. (2025) · Journal of Proteome Research · doi:10.1021/acs.jproteome.5c00300 · Cited by 8
El-Wahab, E. W. A., Metwally, M., & Lotfy, N. A. (2021) · Tropical Medicine & International Health · doi:10.1111/tmi.13588 · Cited by 9
“In a meta-analysis of 11 studies, chronic HCV infection was found to significantly impair HBV vaccine response [61], probably though genetic modifications in the B-cell lineage leading to lower frequencies in memory B cells [62].”
Preimmunization correlates of protection shared across malaria vaccine trials in adults
Neal, M. L., Duffy, F. J., Du, Y., Aitchison, J. D., & Stuart, K. D. (2022) · npj Vaccines · doi:10.1038/s41541-021-00425-1 · Cited by 12
Gut Microbiome Signatures Linked to HIV-1 Reservoir Size and Viremia ControlPreprint
Borgognone, A., Noguera-Julián, M., Oriol-Tordera, B., Noël‐Romas, L., Ruiz‐Riol, M., Guillén, Y., Parera, M., Casadellà, M., Duran-Castells, C., Puertas, M. C., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.10.03.462590 · Cited by 9
(2018) · Nature Communications · doi:10.1038/s41467-018-04085-z · Cited by 9
Fabrication, Characterization, and In Vitro Testing of Quercetin–Copper(II) Complex
Sajid, S., Jahan, N., Huma, Z., Ali, M. I., Zada, A., Ibrar, A., Ashraf, G. A., Noureen, L., Ayaz, M., Arain, S., et al. (2024) · Nano Biomedicine and Engineering · doi:10.26599/nbe.2024.9290085 · Cited by 8
Lodge, S., Masuda, R., Nitschke, P., Beilby, J. P., Hui, J., Hunter, M. L., Yeap, B. B., Millet, Ó., Wist, J., Nicholson, J. K., et al. (2025) · PLoS ONE · doi:10.1371/journal.pone.0311975 · Cited by 9
Heterogeneity of thymic output in the elderly and its association with sex and smoking
Sandhar, B. S., Vyas, V. S., Harding, D., Ragazzini, R., Bonfanti, P., Marelli‐Berg, F. M., Bell, C. G., Chain, B., & Longhi, M. P. (2025) · JCI Insight · doi:10.1172/jci.insight.189008 · Cited by 11
“Interestingly, most of these genes have been found to negatively correlate with age (46).”
van der Heiden, M., Berbers, G. A. M., Fuentes, S., van Zelm, M. C., Boots, A. M. H., & Buisman, A. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01962 · Cited by 9
“In addition, information on the genetic background of the participants could have added to the predictive factors in our analysis, since several studies found associations between genetic signatures and vaccine responsiveness [24, 30, 31].”
BackgroundResultKim, J. W., Kwon, K. W., Kim, M., & Cho, J. Y. (2022) · Plants · doi:10.3390/plants11131750 · Cited by 8
Charnier, C., Latrille, É., Roger, J., Miroux, J., & Steyer, J. (2018) · Chemical Engineering & Technology · doi:10.1002/ceat.201700581 · Cited by 8
Towards a Systems Immunology Approach to Understanding Correlates of Protective Immunity against HCV
Shoukry, N. H. (2021) · Viruses · doi:10.3390/v13091871 · Cited by 8
Dobbs, K. R., Atieli, H., Valim, C., & Beeson, J. G. (2024) · American Journal of Tropical Medicine and Hygiene · doi:10.4269/ajtmh.23-0696 · Cited by 8
A multi-omics systems vaccinology resource to develop and test computational models of immunity
Shinde, P. S., Soldevila, F., Reyna, J., Aoki, M., Rasmussen, M., Willemsen, L., Kojima, M., Ha, B., Greenbaum, J., Overton, J. A., et al. (2024) · Cell Reports Methods · doi:10.1016/j.crmeth.2024.100731 · Cited by 15
Ramos, I. (2025) · mSphere · doi:10.1128/msphere.00502-24 · Cited by 7
“A signature of 15 genes (Table 1) was derived from this study and was shown to predict the magnitude of the antibody response to vaccination with an AUROC of 0.62 (21).”
InfluentialVaccination choices for older people, looking beyond age specific approaches
Aspinall, R., & Lang, P. O. (2017) · Expert Review of Vaccines · doi:10.1080/14760584.2018.1411197 · Cited by 7
One vaccine for life: Lessons from immune ontogeny
Brophy‐Williams, S., Fidanza, M., Marchant, A., Way, S. S., & Kollmann, T. R. (2021) · Journal of Paediatrics and Child Health · doi:10.1111/jpc.15511 · Cited by 7
Izmirly, A. M., Pelletier, A., Connors, J. R., Taramangalam, B., Alturki, S. O., Gordon, E. A., Alturki, S. O., Mell, J. C., Swaminathan, G., Karthik, V., et al. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1009903 · Cited by 9
“profiles and pro-inflammatory status at the time of vaccination were correlative of poor vaccine outcome [50].”
BackgroundSelf-citationNasb, M., Li, F., Dayoub, L., Wu, T., Wei, M., & Chen, N. (2024) · Journal of Advanced Research · doi:10.1016/j.jare.2024.04.034 · Cited by 12
Vaccine responses in ageing and chronic viral infection
Rees-Spear, C., & McCoy, L. E. (2021) · Oxford Open Immunology · doi:10.1093/oxfimm/iqab007 · Cited by 11
“interferon pathways leading to expression of TNF, along with IFNG, has also been correlated with age and reduced antibody titres [23].”
BackgroundInfluentialSantos‐Peral, A., Zaucha, M., Nikolova, E., Yaman, E., Puzek, B., Winheim, E., Goresch, S., Scheck, M. K., Lehmann, L., Dahlström, F., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.101946 · Cited by 8
Mehta, G., Riva, A., Ballester, M. P., Uson, E., Pujadas, M., Carvalho‐Gomes, Â., Sahuco, I., Bono, A., D’Amico, F., Viganò, R., et al. (2023) · Hepatology Communications · doi:10.1097/hc9.0000000000000273 · Cited by 6
Social determinants and BCG efficacy: a call for a socio-biological approach to TB prevention
Dowd, J. B., Fletcher, H. A., & Boccia, D. (2018) · F1000Research · doi:10.12688/f1000research.14085.1 · Cited by 6
Creighton, R., Schuch, V., Urbanski, A. H., Giddaluru, J., Costa-Martins, A. G., & Nakaya, H. I. (2020) · Seminars in Immunology · doi:10.1016/j.smim.2020.101420 · Cited by 9
Zelkoski, A. E., Goguet, E., Darcey, E. S., Alameh, M., Said, H., Pollett, S. D., Powers, J. H., Laing, E. D., Olsen, C. H., Mitre, E. E. S., et al. (2025) · Vaccines · doi:10.3390/vaccines13070718 · Cited by 6
“The role of IFN production in vaccine responses is complex, as it has been shown to associate with the adaptive response in some platforms, such as inactivated vaccines [23,26,44], but not all [22].”
Pozo‐Balado, M. D. M., Bulnes‐Ramos, Á., Olivas‐Martínez, I., Garrido‐Rodríguez, V., Lozano, C., Álvarez‐Ríos, A. I., Sánchez-Sánchez, B., Sánchez-Bejarano, E., Maldonado-Calzado, I., Martín-Lara, J. M., et al. (2023) · Immunity & Ageing · doi:10.1186/s12979-023-00334-y · Cited by 5
“Thus, the benefits of vaccination in the prevention of infectious diseases are limited in older people, who normally show defective humoral responses to several vaccines [4], such as Influenza [5, 6], Hepatitis B virus [17], and SARS-CoV2 [1, 18–21].”
BackgroundVaccinomics and adversomics: key elements for a personalized vaccinology
Laganà, A., Visalli, G., Pietro, A. D., & Facciolà, A. (2024) · Clinical and Experimental Vaccine Research · doi:10.7774/cevr.2024.13.2.105 · Cited by 5
Mulé, M. P., Martins, A., Cheung, F., Farmer, R., Sellers, B., Quiel, J. A., Jain, A., Kotliarov, Y., Bansal, N., Chen, J.-G., et al. (2023) · medRxiv · doi:10.1101/2023.03.20.23287474 · Cited by 4
Pelletier, A., Sánchez, G. P., Izmirly, A. M., Watson, M. A., Pucchio, T. D., Carvalho, K. I., Filali-Mouhim, A., Paramithiotis, E., Timenetsky, M. D. C. S. T., Precioso, A. R., et al. (2022) · Cell Reports · doi:10.1016/j.celrep.2024.114370 · Cited by 7
“30 Moreover, pre-vaccination transcriptional signatures for influenza, HepB, malaria, and yellow fever vaccination 17,19,31,32 also have been identified.”
BackgroundMethodInfluentialSelf-citationHu, C., Hu, W., Tang, B., Bao, Q., Jiang, X., Tang, L., Wang, H., He, L., Lv, M., Xiao, Y., et al. (2024) · iScience · doi:10.1016/j.isci.2024.108851 · Cited by 5
Nemani, K., Picker, L. D., Dickerson, F., Leboyer, M., Santacatterina, M., Ando, F., Capichioni, G., Smith, T. E., Kammer, J., Abdellati, K. E., et al. (2024) · Brain Behavior & Immunity - Health · doi:10.1016/j.bbih.2024.100802 · Cited by 6
“…increased frequencies of proinflammatory innate immune cells at baseline correlate with lower antibody responses to Hepatitis B vaccination (Fourati et al., 2016), and higher frequencies of exhausted and activated natural killer cells are associated with lower antibody titers to the yellow…”
Fehér, C., Pastor-Ibáñez, R., Leal, L., Plana, M., Arnedo, M., van den Ham, H., Andeweg, A. C., Gruters, R. A., Díez‐Fuertes, F., Alcamı́, J., et al. (2021) · Vaccines · doi:10.3390/vaccines9070799 · Cited by 4
“Systems vaccinology has proven to be useful in multiple infectious diseases, such as influenza [5], yellow fever [6], hepatitis B [7], or ebola [8].”
BackgroundInvestigation of Pancreatic-beta Cells Role in the Biological Process of Ageing
Chaudhary, R., Khanna, J., Rohilla, M., Gupta, S., & Bansal, S. (2023) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/1871530323666230822095932 · Cited by 6
Systems Biological Approaches for Mucosal Vaccine Development
Pulendran, B. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-811924-2.00045-6 · Cited by 4
Youssry, S., Shalaby, T. I. A., Maher, A.-S., & Ghoneim, H. (2022) · Immunologic Research · doi:10.1007/s12026-022-09287-8 · Cited by 4
Beyond one virus: vaccination against hepatitis B after hepatitis C treatment
Debes, J. D., & Singh, D. (2018) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(18)30076-8 · Cited by 4
Papadatou, I., Geropeppa, M., Piperi, C., Spoulou, V. I., Adamopoulos, C., & Papavassiliou, A. G. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25137095 · Cited by 3
“…upregulation of pro-inflammatory pathways prevailed in elderly participants, including modules of cell motility, the inhibition of integrin signaling, a type II interferon signaling module with expression of TNF and IFN γ , complement genes, and T cell-and NK-cell-mediated cytolysis markers [25].”
BackgroundResultZhang, Y., Zhao, L., Zhang, J., Zhang, X., Han, S., Sun, Q., Yao, M., Pang, B., Duan, Q., & Jiang, X. (2024) · Immunity & Ageing · doi:10.1186/s12979-023-00408-x · Cited by 3
Gut bacteria-derived sphingolipids alter innate immune responses to oral cholera vaccine antigens
Chac, D., Heller, F. J., Banna, H. A., Kaisar, M. H., Markiewicz, S. M., Pruitt, E. L., Chowdhury, F., Bhuiyan, T. R., Akter, A., Khan, A. I., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-67388-y · Cited by 4
Lin, X., Twelkmeyer, T., Zhu, D., Zhang, L., Zhao, Y., Zhang, C., Iwakura, Y., Meng, G., Hua, Z., Yan, B., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2019798118 · Cited by 18
“This supported a previous study in elderly participants, in which the poor response to HBV vaccine associated with increased IL-1Ra messenger RNA (mRNA) levels (34).”
BackgroundResultUndetectable Anti-HBs Antibodies: Need of a Booster Dose for HIV-1-Infected Individuals
Bekele, Y., Berzofsky, J. A., & Chiodi, F. (2021) · Vaccines · doi:10.3390/vaccines9121484 · Cited by 3
Cytomegalovirus Pneumonia in a Patient with Down Syndrome
Perrotta, F., Piscopiello, D., Rizzo, D., Iosa, G., Garzya, G., Calò, P., & Gemma, D. (2024) · Medicina · doi:10.3390/medicina60020242 · Cited by 2
“The administration of baricitinib, through inhibition of JAKq/JAK2, could reduce underlying inflammation in individuals with DS and restore immune homeostasis and the ability to trigger a more durable antibody response to vaccines [43].”
BackgroundTakagi, Y., Nishimura, T., Aktar, S., Katayama, D., Takashima, K., Kawakita, T., Sekiya, T., Shingai, M., Tanaka, H., Akita, H., et al. (2025) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2025.102784 · Cited by 2
Hu, J. P., Huang, K., Zou, H., & Li, J. (2025) · Frontiers in Public Health · doi:10.3389/fpubh.2025.1480766 · Cited by 3
Li, L., Yang, Z., Liu, H., He, Z., Wen, Z., Chen, H., Zhang, Z., Liu, Z., Fan, X., Liu, L., et al. (2025) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.5c03743 · Cited by 5
Plasma Cytokines and Birth Weight as Biomarkers of Vaccine-Induced Humoral Responses in Piglets
Lipsit, S., Facciuolo, A., Scruten, E., Griebel, P. J., & Napper, S. (2022) · Frontiers in Veterinary Science · doi:10.3389/fvets.2022.922992 · Cited by 5
“Similarly, activation of innate immune cells and the upregulation of both pro-inflammatory gene signaling pathways and pro-inflammatory cytokines were associated with reduced seroconversion to a hepatitis B vaccine in older humans (24).”
BackgroundResultNovel Technologies to Improve Vaccines for Older Adults
Laupèze, B., der Most, R. G. V., & Giudice, G. D. (2020) · Interdisciplinary topics in gerontology and geriatrics · doi:10.1159/000504485 · Cited by 2
A Summary of the Second Annual HIV Microbiome Workshop
Williams, B., Ghosh, M., Boucher, C. A., Bushman, F. D., Carrington‐Lawrence, S., Collman, R. G., Dandekar, S., Dang, Q., Malaspina, A., Paredes, R., et al. (2017) · AIDS Research and Human Retroviruses · doi:10.1089/aid.2017.0137 · Cited by 3
Senkpeil, L., Bhardwaj, J., Little, M. R., Holla, P., Upadhye, A., Swanson, P. A., Wiegand, R. E., Macklin, M. D., Bi, K., Flynn, B. J., et al. (2021) · medRxiv · doi:10.1101/2021.10.08.21264577 · Cited by 2
Naidu, A., Garg, V., Balakrishnan, D., Vinaya, C. R., Sundararajan, V., & Sajitha Lulu, S. (2024) · Molecular Immunology · doi:10.1016/j.molimm.2024.03.005 · Cited by 1
Immuno-Microbial Signature of Vaccine-Induced Immunity against SARS-CoV-2
Umeda, L., Torres, A., Kunihiro, B. P., Rubas, N. C., Wells, R. K., Phankitnirundorn, K., Peres, R., Juárez, R., & Maunakea, A. K. (2024) · Vaccines · doi:10.3390/vaccines12060637 · Cited by 1
“An increased presence of pro-inflammatory innate immune cells correlated with a decreased response to the hepatitis B virus vaccination in aged individuals [11].”
BackgroundAdvanced immunology in aging population: unveiling the complexities of vaccine responsiveness
Han, Y., Huang, Y., Zhou, Y., He, W., Luo, G., Yang, L., Chen, Y., Zhu, Y., Jiang, W., Xiao, C., et al. (2025) · Frontiers in Aging · doi:10.3389/fragi.2025.1682763 · Cited by 1
Andersson, S. H. A., Chalou, A., Mulholland, M., Katra, P., Ljungcrantz, I., Andersson, L. I. M., Engström, G., Nilsson, J. Å., Șchiopu, A., Björkbacka, H., et al. (2025) · European Heart Journal Open · doi:10.1093/ehjopen/oeaf167 · Cited by 1
“The observed association between low-grade inflammation and poor vaccine response aligns with previous reports 8 and warrants further mechanistic studies.”
Ismail, J., Tamilselvan, B., Rubsamen, M., Petrosky, J., Richardson, B., Zagore, L. L., Oyebanji, O. A., Keresztesy, D., Payne, M., Wilk, D. J., et al. (2026) · iScience · doi:10.1016/j.isci.2026.115730 · Cited by 1
Systems vaccinology and the architecture of human immunity
Pulendran, B. (2026) · Nature · doi:10.1038/s41586-026-10753-8 · Cited by 2
“These signatures were validated in an independent cohort of vaccinees (trial 2), and machine learning was used to predict the magnitude of the CD8 + T cell and neutralizing antibody responses. responsiveness 18,24,31,32,35,36,50,69,70 .”
Praet, J. T. V., Groote, M. D., Bacquer, D. D., Verhalleman, E., Welvaert, Z., Emmerechts, J., Reynders, M., & Vriese, A. S. D. (2022) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofac585 · Cited by 2
“In accordance, only B-cell immune markers (proportions of switched IgG memory B cells and IgG memory B cells) predicted the humoral response after hepatitis B vaccination [22].”
Garse, S., Dokhale, S., Bhandari, G. K., Kapadiya, V., Prabhakar, K., & Devarajan, S. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15526-0.00002-0 · Cited by 1
Antiviral CD4+ T and myeloid cell responses to influenza vaccines are attenuated in older adults
Oakes, J. M., Simmons, J., Nochowicz, C. H., Kirk, L. A., Eason, J., Halasa, N., Talbot, H. K., Bailin, S. S., Castilho, J. L., & Kalams, S. A. (2026) · Communications Medicine · doi:10.1038/s43856-026-01586-7 · Cited by 1
Vacinas contra a infecção pelo SARS-CoV-2
Silva, T. C., de Andrade, A. B. M. D. G., Barral-Neto, M., & Boaventura, V. S. (2020) · EDUFBA eBooks · doi:10.9771/9786556300443.009 · Cited by 1
Lipsit, S., Facciuolo, A., Scruten, E., Wilkinson, J., Plastow, G. S., KUSALIK, A. J., & Napper, S. (2022) · Vaccine X · doi:10.1016/j.jvacx.2022.100167 · Cited by 2
“This includes defining gene expression events in response to vaccines against yellow fever virus [14], influenza virus [20,36,37], hepatitis B virus [10], shingles virus [27] tetanus toxoid [1], foot-andmouth-disease virus [22], and Mycoplasma hyopneumoniae (M.”
BackgroundInfluentialImmunopharmacology and Immunotoxicology Assessment of Vaccines and Adjuvants
Wolf, J. J. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-801238-3.64181-8
Profiling Vaccines for an Immunosenescent and Multimorbid Population
Rappuoli, R. (2019) · Practical issues in geriatrics · doi:10.1007/978-3-030-05159-4_7
Optimizing hepatitis B prevention and control
Raven, S. F. H. (2021) · Research Publications (Maastricht University) · doi:10.26481/dis.20211001cr
Senkpeil, L., Bhardwaj, J., Little, M. R., Holla, P., Upadhye, A., Swanson, P. A., Wiegand, R. E., Macklin, M. D., Bi, K., Flynn, B. J., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3946574 · Cited by 2
Nieman, D. C. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737032981.793575943
Pelletier, A. N., Sánchez, G. P., Izmirly, A. M., Watson, M. A., Pucchio, T. D., Carvalho, K. I., Filali-Mouhim, A., Paramithiotis, E., Kalil, J. E., Timenetsky, M. D. C. S. T., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4113517
Self-citationA systems vaccinology resource to develop and test computational models of immunityPreprint
Shinde, P. S., Soldevila, F., Reyna, J., Aoki, M., Rasmussen, M., Willemsen, L., Kojima, M., Ha, B., Greenbaum, J., Overton, J. A., et al. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.08.28.555193
Bashir, S., Wilson, M., Ashiru-Oredope, D. A. I., & Murdan, S. (2023) · AAPS advances in the pharmaceutical sciences series · doi:10.1007/978-3-031-35811-1_9
Immune Response to COVID-19 Vaccination in Frail PatientsPreprint
Liao, S., Wu, L., Li, S., zheng, X., Xu, J., Zhang, X., Yin, M., Ni, J., Zhang, Q., & Yu, Z. (2024) · Research Square · doi:10.21203/rs.3.rs-3896432/v1
Additional file 3 of Gut microbiome signatures linked to HIV-1 reservoir size and viremia control
Borgognone, A., Noguera-Julián, M., Oriol-Tordera, B., Noël‐Romas, L., Ruiz‐Riol, M., Guillén, Y., Parera, M., Casadellà, M., Duran-Castells, C., Puertas, M. C., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19581798
Additional file 4 of Gut microbiome signatures linked to HIV-1 reservoir size and viremia control
Borgognone, A., Noguera-Julián, M., Oriol-Tordera, B., Noël‐Romas, L., Ruiz‐Riol, M., Guillén, Y., Parera, M., Casadellà, M., Duran-Castells, C., Puertas, M. C., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19581801
Immunopharmacology and Immunotoxicology Assessment of Vaccines and Adjuvants
Wolf, J. J. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-95488-4.00052-8
Heterogeneity of thymic output in elderly and its association with sex and smokingPreprint
Longhi, M. P., Sandhar, B. S., Vyas, V. S., Harding, D., Ragazzini, R., Bonfanti, P., Marelli‐Berg, F. M., Bell, C. G., & Chain, B. (2024) · Research Square · doi:10.21203/rs.3.rs-3559323/v1
Miller, J. L., Leedale, C., Kang, D., Lilue, J., Harder, O. E., & Niewiesk, S. (2025) · Journal of Virology · doi:10.1128/jvi.01863-24 · Cited by 1
“Increased expression of inflammatory genes prior to hepatitis B vaccination is predictive of a weaker response to the vac cine (75, 76).”
Hu, M., & Pulendran, B. (2025) · Elsevier eBooks · doi:10.1016/b978-0-12-824465-4.00227-1
Immuno-functionomics reveals geographical variation and a role for TLR8 in mRNA vaccine responses
Huisman, W., Azimi, S., Nguyen, T. Y. N., de Kroon, A. C., de Ruiter, K., Tahapary, D. L., Manurung, M. D., Pothast, C. R., Kruize, Y. C. M., Heemskerk, M. H. M., et al. (2025) · iScience · doi:10.1016/j.isci.2025.113839
Pozo‐Balado, M. D. M., Bulnes‐Ramos, Á., Olivas‐Martínez, I., Garrido‐Rodríguez, V., Lozano, C., Álvarez-Ríos, A. I., Sánchez-Sánchez, B., Sánchez-Bejarano, E., Maldonado-Calzado, I., Martín-Lara, J. M., et al. (2023) · DIGITAL.CSIC (Spanish National Research Council (CSIC)) · doi:10.6084/m9.figshare.22623208
Additional file 2 of Gut microbiome signatures linked to HIV-1 reservoir size and viremia control
Borgognone, A., Noguera-Julián, M., Oriol-Tordera, B., Noël‐Romas, L., Ruiz‐Riol, M., Guillén, Y., Parera, M., Casadellà, M., Duran-Castells, C., Puertas, M. C., et al. (2022) · Figshare · doi:10.6084/m9.figshare.19581792
Pozo‐Balado, M. D. M., Bulnes‐Ramos, Á., Olivas‐Martínez, I., Garrido‐Rodríguez, V., Lozano, C., Álvarez-Ríos, A. I., Sánchez-Sánchez, B., Sánchez-Bejarano, E., Maldonado-Calzado, I., Martín-Lara, J. M., et al. (2023) · DIGITAL.CSIC (Spanish National Research Council (CSIC)) · doi:10.6084/m9.figshare.22623190
Pozo‐Balado, M. D. M., Bulnes‐Ramos, Á., Olivas‐Martínez, I., Garrido‐Rodríguez, V., Lozano, C., Álvarez-Ríos, A. I., Sánchez-Sánchez, B., Sánchez-Bejarano, E., Maldonado-Calzado, I., Martín-Lara, J. M., et al. (2023) · DIGITAL.CSIC (Spanish National Research Council (CSIC)) · doi:10.6084/m9.figshare.22623199
Zhang, Y., Zhao, L., Zhang, J., Zhang, X., Han, S., Sun, Q., Yao, M., Pang, B., Duan, Q., & Jiang, X. (2024) · Figshare · doi:10.6084/m9.figshare.26673522
Zhang, Y., Zhao, L., Zhang, J., Zhang, X., Han, S., Sun, Q., Yao, M., Pang, B., Duan, Q., & Jiang, X. (2024) · Figshare · doi:10.6084/m9.figshare.25097324
Zhang, Y., Zhao, L., Zhang, J., Zhang, X., Han, S., Sun, Q., Yao, M., Pang, B., Duan, Q., & Jiang, X. (2024) · Figshare · doi:10.6084/m9.figshare.25097357
Pozo‐Balado, M. D. M., Bulnes‐Ramos, Á., Olivas‐Martínez, I., Garrido‐Rodríguez, V., Lozano, C., Álvarez-Ríos, A. I., Sánchez-Sánchez, B., Sánchez-Bejarano, E., Maldonado-Calzado, I., Martín-Lara, J. M., et al. (2023) · DIGITAL.CSIC (Spanish National Research Council (CSIC)) · doi:10.6084/m9.figshare.22623205
Pozo‐Balado, M. D. M., Bulnes‐Ramos, Á., Olivas‐Martínez, I., Garrido‐Rodríguez, V., Lozano, C., Álvarez-Ríos, A. I., Sánchez-Sánchez, B., Sánchez-Bejarano, E., Maldonado-Calzado, I., Martín-Lara, J. M., et al. (2023) · DIGITAL.CSIC (Spanish National Research Council (CSIC)) · doi:10.6084/m9.figshare.22623196
Pozo‐Balado, M. D. M., Bulnes‐Ramos, Á., Olivas‐Martínez, I., Garrido‐Rodríguez, V., Lozano, C., Álvarez-Ríos, A. I., Sánchez-Sánchez, B., Sánchez-Bejarano, E., Maldonado-Calzado, I., Martín-Lara, J. M., et al. (2023) · DIGITAL.CSIC (Spanish National Research Council (CSIC)) · doi:10.6084/m9.figshare.22623202
Pozo‐Balado, M. D. M., Bulnes‐Ramos, Á., Olivas‐Martínez, I., Garrido‐Rodríguez, V., Lozano, C., Álvarez-Ríos, A. I., Sánchez-Sánchez, B., Sánchez-Bejarano, E., Maldonado-Calzado, I., Martín-Lara, J. M., et al. (2023) · DIGITAL.CSIC (Spanish National Research Council (CSIC)) · doi:10.6084/m9.figshare.22623211
Pozo‐Balado, M. D. M., Bulnes‐Ramos, Á., Olivas‐Martínez, I., Garrido‐Rodríguez, V., Lozano, C., Álvarez-Ríos, A. I., Sánchez-Sánchez, B., Sánchez-Bejarano, E., Maldonado-Calzado, I., Martín-Lara, J. M., et al. (2023) · DIGITAL.CSIC (Spanish National Research Council (CSIC)) · doi:10.6084/m9.figshare.22623193
Maxwell, J., Joyner, J. A., Norton, J. E., Knapp, W., Wang, I., Swaminathan, G., Monslow, M. A., & Citron, M. P. (2026) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2026.2689208
“26 The transcriptomics ‑ based bioage signature that was built and validated was derived from approximately 1,240 individuals aged 15–94 to identify genes associated with biological age.”
Self-citationMahajan, A. S., Ravichandran, S., Marcheş, R., Yazıcı, Y. Y., Nelson, S., Aydillo, T., Kshitija, K., Rojo-Fernandez, A., Nehar-Belaid, D., Kenyon‐Pesce, L., et al. (2026) · medRxiv · doi:10.64898/2026.07.02.26357118
Tfh dysfunction is associated with poor responses to HBV vaccinationPreprint
Chen, H. M., Severa, E., Yao, X., Williams, T., Sinha, R., Monteiro, C., Tuen, M., Dubensky, T. B., Koralov, S. B., Nowosad, C. R., et al. (2026) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.64898/2026.07.30.741822
Pre-vaccine sentinel antibodies predict blunted vaccine responses
Song, L.-S., Park, J. G., Qiu, J., Murugan, V., mousavi, S., Hou, C.-W., Magee, D. M., Chen, Z., Chung, Y., Williams, S., et al. (2026) · Cell press blue · doi:10.1016/j.cpblue.2026.100088
Systems Biology to Identify Biomarkers of Neonatal Vaccine Immunogenicity
Levy, O. (2022) · London School of Hygiene & Tropical Medicine · doi:10.21430/m35pwv2m56
Immune Signatures Data Resource
Thakar, J., Diray-Arce, J., & Kleinstein, S. H. (2025) · ImmPort · doi:10.21430/dh2k-xr58
innate immune responses to AS03 adjuvanted vs. non-adjuvanted H5N1 vaccine
Perl, S. (2024) · ImmPort · doi:10.21430/m3qqegkr3v
Metadata
- Authors
- Fourati, S., Cristescu, R., Loboda, A., Talla, A., Filali, A., Railkar, R., Schaeffer, A. K., Favre, D., Gagnon, D., Peretz, Y., Wang, I.-M., Beals, C. R., Casimiro, D. R., Carayannopoulos, L. N., & Sékaly, R.-P.
- Affiliations
- University Hospitals of Cleveland (US)
- Merck & Co., Inc., Rahway, NJ, USA (United States) (US)
- Caprion (Canada) (CA)
- Corresponding author
- Sékaly, Rafick-Pierre
- ORCID
- Venue
- Nature Communications
- Published
- 2016-01-08
- Volume
- 7
- Issue
- 1
- Pages
- 10369-10369
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC4729923
- OpenAlex
- W2229921221
- Cited by
- 183
- References
- 46
- Citations by year
- 2026: 8 · 2025: 19 · 2024: 23 · 2023: 19 · 2022: 28 · 2021: 24 · 2020: 20 · 2019: 11 · 2018: 16 · 2017: 12 · 2016: 3
- FWCI
- 8.49
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Nature Communications (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Foundation for the National Institutes of Health
- Case Western Reserve University
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune responses and vaccinations
- Health Sciences › Medicine › Epidemiology › Hepatitis B Virus Studies
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- hepatitis B vaccine, immunosenescence, older adults, B cell response, memory B cells, innate immune cells, red blood cell count, vaccine response prediction, cytokines
- MeSH terms
- Adult, Aged, Aged, 80 and over, Aging, B-Lymphocytes, Erythrocyte Count, Female, Flow Cytometry, Hepatitis B Surface Antigens, Humans, Inflammation, Male, Middle Aged, Vaccination, Cohort Studies, Biomarkers, Hepatitis B Vaccines, Transcriptome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.